EyePoint's DURAVYU: Revolutionizing Retinal Care episode artwork

EPISODE · May 7, 2026 · 1 MIN

EyePoint's DURAVYU: Revolutionizing Retinal Care

from The Daily News Now! Business

EyePoint Pharmaceuticals Q1 2026 earnings highlight DURAVYUs potential in wet AMD and DME, with Phase III trials and DME trials progressing. Positive safety data and cash reserves support their push into a $15 billion market. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e66e385178d3a0b3

NOW PLAYING

EyePoint's DURAVYU: Revolutionizing Retinal Care

0:00 1:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 7, 2026.

What is this episode about?

EyePoint Pharmaceuticals Q1 2026 earnings highlight DURAVYUs potential in wet AMD and DME, with Phase III trials and DME trials progressing. Positive safety data and cash reserves support their push into a $15 billion market. Support the...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!